Asthma Clinical Trial
Official title:
The Relationship Between Kinesiophobia, Physical Activity Level and Quality of Life in Asthma Patients
Asthma is a heterogeneous disease characterized by chronic airway inflammation characterized by time-varying respiratory symptoms such as wheezing, shortness of breath, chest tightness and cough, with limitation of expiratory airflow. These variations are often triggered by exercise, exposure to allergens or an irritation, weather changes or viral respiratory diseases (Karakış, 2018). Increased respiratory distress decreases the patient's activity, decreases the condition and makes the individual dependent in daily life. In the studies conducted in asthma patients, the cases stated that they perceived their illness as an obstacle against physical activity and thus they were pushed to immobility (Kırtay & Oğuz, 2011). In the literature, no study on the variable of kinesiophobia in asthma was found. The aim of this study was to investigate the relationship between kinesiophobia and physical activity level and quality of life in asthma patients.
Asthma is a chronic inflammatory disease characterized by increased airway sensitivity to
various stimuli and reversible airway obstruction (Soyuer et al., 2013). Bronchial
hypersensitivity associated with chronic airway inflammation causes wheezing, dyspnea, chest
tightness, and cough attacks, especially at midnight or morning. These attacks are associated
with varying degrees of airway obstruction and usually improve with treatment or
spontaneously (Arslan, 2011). Three mechanisms are responsible for the pathogenesis of
asthma. These include reversible airway obstruction, airway inflammation, and increased
airway sensitivity (Soyuer et al., 2013). Although it is known that genetic and environmental
factors play a role in asthma formation, etiopathogenesis has not been fully explained
(Arslan, 2011). Approximately 300 million people worldwide suffer from asthma and this
prevalence increases by 50% every ten years. Hospitalization is frequently seen in patients
with asthma (Autumn, 2015). It is estimated that approximately 250,000 people die annually
due to asthma. No relationship was found between prevalence and mortality (Autumn, 2015).
Asthmatic patients have intermittent symptoms such as wheezing, dyspnea, chest tightness, and
dry cough. Stimulants such as allergens, air pollution, gastroesophageal reflux, stress and
exercise cause these symptoms. 90% of untreated asthmatics develop asthma symptoms during
exercise (Dursun et al., 2013). Airway obstruction due to exercise occurs in 40-90% of
asthmatics, decreases the ability to exercise and patients prefer a more sedentary lifestyle.
Patients with asthma have low physical activity levels because they avoid exercising due to
anxiety and depression, inactivity, fatigue, dyspnea (Autumn, 2015). The ability to perform
activities and the ability to perform daily living activities are components of quality of
life. In many studies, it has been found that quality of life is affected in individuals with
chronic lung disease. Quality of life can be assessed with many disease-specific
questionnaires. Asthma patients experience problems in many areas in terms of quality of
life, including day and night disease symptoms, impaired daily living activities, and reduced
quality of life. Asthma is associated with decreased quality of life and morbidity. Asthma
symptoms reduce performance at school and at work; affects learning and reduces quality of
life. It is stated that asthma has a negative effect on quality of life, physical,
physiological and social function (Autumn, 2015).
Airway obstruction due to exercise decreases physical activity in asthmatic patients. This
may give rise to fear of movement over time. Avoidance of movement is called kinesiophobia.
Kinesiophobia is a condition that occurs when patients want to perform their previous
functions, especially in chronic painful disease processes.
Kinesiophobia is an avoidance phenomenon within the cognitive behavioral avoidance model and
patients may limit their activity in daily life in case of symptoms of deterioration or the
occurrence of symptoms. This may result in emotional problems and life dissatisfaction in
later periods (Yumin et al., 2017). Kinesiophobia has been the subject of study in
cardiopulmonary cases, but there is no research on kinesiophobia in asthma. In this study,
the effect of kinesiophobia on physical activity level and quality of life in asthma will be
investigated.
;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|